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ABSTRACT 
Introduction: Translating research evidence into clinical practice often uses key 
performance indicators (KPIs) to monitor quality of care.  We conducted a systematic 
review to identify the stroke KPIs used in large registries, and to estimate their association 
with patient outcomes. 
Method: We sought publications of recent (January 2000-May 2017) national or regional 
stroke registers reporting the association of KPIs with patient outcome (adjusting for age 
and stroke severity). We searched Ovid Medline, EMBASE and PubMed and screened 
references from bibliographies. We used an inverse variance random effects meta-analysis 
to estimate associations (odds ratio; 95% Confidence Interval) with death or poor outcome 
(death or disability) at the end of follow up. 
Findings: We identified 30 eligible studies (324,409 patients). The commonest KPIs were 
swallowing/nutritional assessment, stroke unit admission, antiplatelet use, brain imaging, 
anticoagulant use, lipid management, deep vein thrombosis prophylaxis and early 
physiotherapy/mobilization.  Lower case fatality was associated with stroke unit admission 
(OR 0.79; 0.72-0.87), swallow/nutritional assessment (OR 0.78; 0.66-0.92), antiplatelet 
(OR 0.61; 0.50-0.74) or anticoagulant use (OR 0.51; 0.43-0.64) for ischemic stroke, lipid 
management (OR 0.52; 0.38-0.71), and early physiotherapy or mobilization (OR 0.78; 
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0.67-0.91). Reduced poor outcome was associated with adherence to swallowing/nutritional 
assessment (OR 0.58; 0.43-0.78) and stroke unit admission (OR 0.83; 0.77-0.89). 
Adherence with several KPIs appeared to have an additive benefit. 
Discussion: Adherence with common KPIs was consistently associated with a lower risk of 
death or disability after stroke. 
Conclusion: Policy makers and health care professionals should implement and monitor 
those KPIs supported by good evidence. 
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INTRODUCTION 
In recent years there have been concerted efforts to develop and implement clinical practice 
guidelines for the management of patients with acute stroke (1). Clinical guidelines are 
written to promote diagnostic or therapeutic interventions applicable to the majority of 
patients in most circumstances. However, the use of guideline recommendations for 
individual patients has traditionally been left to the discretion of individual clinicians (2). A 
recognised approach to assist the translation of research evidence into clinical practice is to 
monitor the quality of care using standardized performance indicators (3) also called quality 
indicators, process of care measures or key performance indicators (KPIs).  Performance 
indicators are standards of care that imply that health care professionals are providing 
inadequate care if eligible patients do not receive that standard of care. Performance 
indicators can be used to monitor the adherence to current guidelines, and support the 
transfer of new evidence into everyday clinical practice (4). 
 
There are now numerous stroke interventions that have been shown to improve patient 
outcomes in research trials; admission to specialized stroke units, use of intravenous 
thrombolysis, mechanical thrombectomy, antiplatelet drugs, anticoagulants, and 
management of fever, hyperglycaemia, and swallowing dysfunction for selected patient 
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groups (5-9).  However, application into routine practice is challenging and regular 
monitoring is important (10).  Ideally, implementation of clinical evidence can be 
demonstrated using a range of stroke KPIs, which offer proxy measures for ideal care being 
delivered. In turn this would lead to evidence of better patient outcomes (11).  
 
 In a previous systematic review of the association between stroke quality (performance) 
indicators and patient-centered outcomes, out of 14 studies that met the eligibility criteria; 
nine had mostly positive associations, whereas five reported little or no association with a 
lower risk for mortality, disability, medical complications, stroke recurrence, or patient 
dissatisfaction (12). A limitation of this review was the exclusion of stroke unit care as a 
performance indicator. With the ongoing developments in clinical guidelines and quality 
indicators for monitoring the application of these guidelines (10,13), we believe that there 
is a need for up-to date comprehensive information on KPIs for stroke care. 
 
We aimed to conduct a systematic literature review to identify the KPIs that have been 
described in stroke care and to summarise their association with patient outcomes.  We 
intend that information gathered from this review will provide decision makers and health 
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care professionals with information on reliable and meaningful KPIs that can be 
implemented to improve outcomes post stroke.  
 
METHODS 
This review was performed according to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (14). This review was registered in 
Prospero Database (CRD42016050798). 
Search strategy  
Searching sources were Ovid Medline, Embase and PubMed databases, and relevant 
references from screening the bibliographies of the initial articles included in the search. 
We used Medical Subject Headings (MeSH) and all subheading terms including “stroke”, 
“cerebrovascular accident”, “cerebrovascular disease”, “cerebrovascular disorders”, “brain 
hemorrhage”, “intracranial hemorrhages”, “brain infarction”, “subarachnoid hemorrhage”, 
“health care quality”, “quality of health care” “quality indicators, health care”, “quality 
assurance, health care”, “quality control”, “quality indicator”, “performance indicator”, 
“register”, “registries”, “clinical audit”, “treatment outcome” , “case fatality rate”, 
“mortality”, “survival”, “disability”, “functional status”,” hospitalization”, “cost”, “quality 
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of life”, “complication”, “hospital discharge” and “stroke recurrence”. Our search was 
restricted to full-text manuscripts published in English from January 1st, 2000 to May 24th, 
2017. 
The search strategies for different databases are detailed in the Online Supplement. 
 
Inclusion criteria: We included national or regional registers that recorded the independent 
association (after adjusting for at least age and a measure of stroke severity) between the 
KPIs and stroke patient outcomes, and involved patients from at least three hospitals. 
Exclusion criteria: We excluded reports that were reviews or did not provide odds ratio 
(OR), hazard ratio (HR) or rate ratio (RR) data. 
Screening and quality assessment 
One author (GU) reviewed each title and excluded obviously irrelevant studies. Articles 
identified as potentially relevant underwent a full review by two authors (GU and PL) to 
determine if they met the inclusion criteria. In cases of disagreement, final determination 
was by discussion and consensus.  
Data extraction 
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We used a standardized form to record information on country, main inclusion or exclusion 
criteria for the recruitment of participants, sample size, stroke severity measure, key 
performance indicators (KPIs) and outcome(s) reported, and reported results (and 95% 
confidence interval). 
 
Data analysis 
Initially, the identified KPIs and their association with the patient outcomes were 
categorized on whether the authors reported a significant association between the KPI and 
patient outcome. There was then a further quantitative analysis (meta-analysis) of the 
relationship (adjusted for at least age and stroke severity) between the KPIs identified and 
patient outcomes. Some checking of the consistency of KPIs and outcomes was required 
with grouping of similar KPIs. For the meta-analysis, we sought information on case 
fatality and poor outcome (death and disability or requiring support) after stroke.   
The meta-analysis was done using the Review Manager (version 5.3) software. Log ORs 
were combined using an inverse variance analysis (random effects model). First, we 
assumed that HRs and RRs approximate the ORs and performed the primary meta-analysis 
including all studies reporting on association of KPIs with case fatality and poor outcome. 
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Second, we performed sensitivity meta-analysis by excluding studies that used HR or RR 
as measures of association.  
 
RESULTS 
The review profile is shown in Figure 1. We identified 3606 references from which 30 
studies (15-44) were eligible for the qualitative review. Among these, only 22 were eligible 
for the meta-analysis. 
 
 
 
 
 
 
 
 
Figure 1: Review profile showing selection of studies 
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 Abbreviations: HR, hazard ratio; KPI, key performance indicator; OR, odds ratio. 
                          Included studies 
Table 1 shows the studies considered for our systematic literature review. Most of the 
included studies (15-29) were conducted in Europe: One European study (15) was 
multinational (across ten countries), the rest were conducted in Denmark (6), Sweden (2), 
United Kingdom (3) (one in England and two in Scotland), Italy (1), Spain (1), and Greece 
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Records screened  
(n =2887) 
Records excluded on title (2728) and full text 
not available (27)  
  (n =2755) 
 
Full-text articles assessed for 
eligibility  
(n =132) 
Full-text articles excluded for their aims (80), 
lack of case mix adjustment (10), conducted at 
one hospital (9), not reporting independent 
KPI (1), not reporting  OR or HR (2) 
(n = 102) 
Studies included in qualitative 
synthesis  
(n = 30) 
Studies included in quantitative 
synthesis (meta-analysis) 
(n = 22) 
Articles excluded for reporting on stroke care 
bundles only and differently (study reference 
34, 36, 38), or being unique reporting on an 
association between a KPI and an outcome 
(study reference 18, 19, 20, 21, 31) 
(n=8) 
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(1). The non-European studies were conducted in the USA, Canada, Chile, Australia, New 
Zealand, China, Thailand and Taiwan. Two reports from Denmark (17,18) and two from 
Scotland (24,25) were based on the same datasets but since they provided associations with 
different outcomes, they were all included in this systematic review. 
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Table 1:  Studies eligible for the systematic literature review  
Study Stroke Type Stroke Severity 
Measure 
Sample size Performance Indicator Patient Outcome OR/ 
HR/ 
RR 
95% CI 
Europe15 SAH excluded Level of 
consciousness, 
incontinence, 
dysphagia, 
dysphasia and 
paralysis 
1847 (10 countries) Brain imaging 3-month  case fatality 0.7 0.4-1.3 
3-month disability (BI≤18)  1.45 0.39–7.4 
Organized stroke carea 3-month case fatality 0.5 0.3-0.8 
3-month disability (BI≤18)  1.3 0.6–1.76 
Denmark16 Ischemic stroke SSS 
Scale (SSS) 
22179(All Danish hospitals) 
hhhospitals) 
Anticoagulation treatment 4-year survival  1.91 1.44-2.52 
Denmark17 SAH excluded SS 29573 (40 hospitals) Specialized stroke unit by 2nd day  90 –day case fatality 0.76  0.69–0.83 
Antiplatelet therapy by 2nd day  0.71  0.62–0.81 
Anticoagulant therapy by 14th day 0.41  0.31–0.52 
CT/MRI scan by first day 1.35 1.24–1.46 
Assessment by a PT  by 2nd day 0.81  0.73–0.88 
Assessment by an OT by 2nd day  0.83  0.75–0.91 
Nutritional risk assessment by 2nd d.  0.69 0.61–0.76 
Number of criteria  fulfilled    
1 vs 0  0.94  0.65-1.49 
2  vs 0  0.78  0.54–1.02 
3  vs 0  0.60  0.42–0.78 
4  vs 0  0.61  0.42–0.79 
5  vs 0  0.45  0.31–0.60 
6  vs 0  0.48  0.31–0.65 
Denmark18 SAH excluded SSS 
 
 
 
 
2636 (7 stroke units) Stroke unit (2nd day) Prolonged LoS  0.71  0.65–0.77 
Antiplatelet (2nd day)  0.80  0.73–0.87 
Anticoagulant  (14th day)  0.78  0.62–0.98 
CT/MRI scan (2nd day)  0.82 0.74–0.91 
PT assessment (2nd  day)  0.87  0.81–0.93 
OT assessment (2nd day)  0.85  0.80–0.91 
Nutritional risk assessment (2nd day)  0.83 0.77–0.90 
Swallowing assessment (2nd  day)  0.78 0.69–0.87 
Constipation risk assessment (2nd day)  0.70  0.63–0.78 
Mobilization (2nd day)  0.67 0.61–0.73 
Intermittent catheterisation (2nd day)  0.77 0.64–0.92 
DVT prophylaxis (2nd day)  0.82 0.71–0.95 
Percentage of criteria fulfilled    
25%–49% vs  0%–24%  0.77  0.69–0.86 
50%–74%  vs  0%–24%  0.67  0.60–0.75 
75%–100%  vs  0%–24%  0.53 0.48–0.59 
Denmark 19 All Ischemic 
strokes 
 SSS 
 
4292 (All Danish  hospitals) Thrombolysis 1.4 years-mortality 0.66 0.49–0.88 
  1.4 years-recurrent stroke 1.05 0.68–1.64 
   1.4 years major bleeding 0.59 0.24–1.47 
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Table 1:  Studies eligible for the systematic literature review    Continued 
 
Denmark20 First ever 
ischemic strokes 
SSS 5070 (Aarhus County) Antidepressants during hospitalization 30-day case fatality 0.28  0.18–0.43 
Denmark21 All stroke types SSS 
 
 
11757 (10 stroke units  in 2 
counties) 
Early admission to a stroke unit Any medical complicationb 
during admission (LoS=13 days) 
 
0.79  0.68–0.92 
 Antiplatelet therapy 0.95  0.79–1.15 
 Anticoagulant therapy  0.59  0.45–0.76 
 CT/MRI scan  1.52  1.35–1.72 
 Assessment by a PT   1.10 0.94-1.28 
 Assessment by an OT  1.10  0.94–1.27 
 Assessment of Nutritional risk  0.87  0.70–1.07 
 Swallowing assessment 0.97  0.84–1.11 
 Early mobilization 0.43  0.35–0.53 
 Percentage of criteria fulfilled   
 25%–49%  vs  0%–24% 0.77  0.67–0.88 
 50%–74%  vs  0%–24% 0.57  0.46–0.70 
 75%–100%  vs  0%–24% 0.50 0.36–0.68 
Sweden22 SAH excluded Level of 
consciousness 
8194 (All hospitals in 
Sweden) 
Stroke unit (Independent before stroke) 2-year case fatality   0.81 0.72-0.92 
2-year functional dependency   0.79 0.66-0.94 
Sweden23 First ever ischemic 
strokes 
ADLs Function 14 529 (All hospitals in 
Sweden) 
Antiplatelet  Therapy 3-month case fatality 0.83 0.68-1.01 
ACE inhibitors Therapy 1.00 0.87–1.14 
Statins Therapy 0.78 0.67–0.91 
Anticoagulants Therapy 0.58 0.44–0.76 
UK 
(England)24  
 
Ischaemic stroke Level of 
consciousness  and  
neurological deficit 
36197 (106 hospitals) Seen by a stroke consultant or associate 
specialist within 24 h hours  
30-day case fatality 0.88 0.80- 0.97 
Brain scan within 24 hours 0.96  0.86- 1.07 
Bundle 1: seen by nurse and one therapist 
within 24 hours and all relevant therapists 
within 72 hours 
0.90  0.82-0.99 
Bundle 2: nutrition screening and formal 
swallow assessment within 72 hours where 
appropriate 
0.76 0.67- 0.87 
Bundle 3: patient’s first ward of admission 
was stroke unit and they arrived there 
within four hours of hospital admission 
0.99  0.90-1.08 
Bundle 4: patient given antiplatelet 
therapy where appropriate and had 
adequate fluid and nutrition for first 72h 
0.46  0.42-0.50 
 
 
    Number of criteria  fulfilled    
    Quality score 5 or 6 v 0-4  0.74 0.66- 0.83 
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Table 1:  Studies eligible for the systematic literature review    Continued 
 
UK 
(Scotland)25 
All stroke types   SSV 36055 (36 hosp) Stroke unit on day 0 or 1 6 month  case fatality 0.79  0.74–0.85 
Swallow screen on day 0  0.95 0.86–1.04 
Brain scan on day 0  0.95  0.88–1.03 
Aspirin on day 0 or 1  0.54  0.49–0.58 
Number of criteria  fulfilled 6 month  case fatality 
0 vs 4  2.26  1.60–3.21 
1 vs 4  1.67  1.45–1.93 
2 vs 4  1.44  1.31–1.59 
3 vs 4  1.17  1.08–1.27 
Number of criteria  fulfilled Discharge to home/usual 
residence at 6 months 
  
0 vs 4  0.70  0.50–0.98 
1 vs 4  0.74  0.65–0.84 
2 vs 4  0.84  0.76–0.91 
3 vs 4  0.91  0.85-0.98 
UK 
(Scotland)26 
All stroke types SSV 41692 (36 hosp) Admission to stroke unit 1-year survival 1.43 2.71-3.56 
 6-month discharged home  1.19 1.11-1.28 
Italy27 All stroke types Level of 
consciousness 
11572 (424 stroke units and 
260 hospitals) 
Stroke Unit 2-year case fatality 0.79  0.68–0.91 
 2-year  death or disability 
(mRS>2) 
0.81  0.72–0.91 
 2 year not living at home 0.85  0.74–0.97 
Spain28 SAH excluded NIHSS 1767 (47 hospitals) Brain imaging  < 24 hours 1-year   case fatality  risk for 
noncompliance 
1.4  0.71–2.76 
Screening of dysphagia 1.23  0.88–1.71 
Antiplatelets  < 48 h for IS 1.3  0.84–2.02 
Early mobilization 1.54  1.05–2.24 
Assessment of rehabilitation needs 1.48  1.06–2.07 
DVT prevention 0.98  0.60–1.60 
Management of hyperthermia 0.67  0.25–1.79 
Management of hypertension 1.87  1.22–2.86 
Management of dyslipidemia   1.29  0.86–1.93 
Anticoagulants  for IS  1.70  0.95–3.05 
Antithrombotics at discharge (IS)  2.79  1.41–5.54 
Greece29 First-ever acute 
ischemic stroke 
SSS 794 (Different  Athenian 
hospitals) 
Statin at discharge 10 year-Case fatality 0.43 0.29-0.61 
 10-year stroke recurrence 0.65 
 
0.39-0.97 
USA30 Ischemic Stroke  NIHSS 1363  (5 hospitals) 
 
Neurology assessment In-hospital mortality, discharge to 
hospice, or discharge to a skilled 
nursing facility 
1.13  0.59-2.17 
Swallowing evaluation 0.64  0.43-0.94 
DVT prophylaxis 0.60  0.37-0.96 
Early mobilization 0.69  0.42-1.14 
Blood pressure  management  1.00  0.67-1.50 
Fever management 0.71 0.35-1.41 
Hypoxia management 0.26  0.09-0.73 
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Table 1:  Studies eligible for the systematic literature review    Continued 
USA31 All stroke types Weakness and 
altered level of 
consciousness 
18017(222 hospitals from 6 
States) 
Dysphagia screening Higher risk of pneumonia for no 
screening 
2.15 1.74-2.66 
Canada32 Ischemic stroke CNS 3631 (11 hospitals) OCIc 1 vs 0 1-year case fatality 
 
0.69  0.44–1.09 
OCI  2 vs 0 0.39  0.25–0.62 
OCI 3 vs 0 0.40 0.25–0.64 
Antithrombotic therapy 0.33  0.22–0.50 
Canada33 Intracerebral 
Haemorrhage  
Stroke 
CNS 2466 (11 hospitals) Statin use in hospital 6 months case fatality  0.2  0.1–0.3 
   Poor outcome (mRS4–6.) at 
discharge 
0.6  0.4–0.9 
Canada34 Ischemic stroke CNS 
 
6223 (12 Centres) OCIc  2–3 vs 0–1 30-day  case fatality 0.23 0.19-0.28 
Chile35 Ischemic stroke 
 
Aphasia, 
hemiplegia, reduced 
level of 
consciousness, and 
speech disturbance 
677 (7 hospitals) Neurological evaluation on admission 30-day  case fatality 2.02  0.77-5.30 
 In-hospital pneumonia 1.07  0.79-1.44 
 
Dysphagia screening within 48hours 
 
30-day  case fatality 
 
0.52 
 
0.26-1.04 
 In-hospital pneumonia 1.58  0.60- 4.15 
Australia36 SAH excluded GCS, ability to lift 
both arms, ability to 
walk, and urinary 
incontinence  
468 (8 hospitals) Thorough (n-l≤1)d adherence to 15 
processes of stroke caree 
Independent at 28 weeks 1.78  0.93–3.38 
Being at home at 28  weeks 1.69  0.86–3.32 
Alive at 28  weeks 2.10 0.92–4.82 
   
Complete (n-l≤0) adherence to 15 
processes of stroke care 
 
Independent at 28  weeks 2.61  0.96–7.10 
Being at home at 28  weeks 3.09   0.96–9.87 
Alive at 28  weeks 3.22 0.66-15.86 
   
Australia37 All stroke types FIM 2119 (108 Rehabilitations 
units) 
ADLs rehabilitation Discharged home (Median LoS= 
26 days) 
1.01 0.33–3.13 
 DVT  prevention 0.58 0.41–0.81 
 Home assessment 6.15 3.70–10.22 
 Balance rehabilitation 0.54 0.35–0.83 
 Secondary prevention on dischargef 1.99 1.12–3.53 
 Education to patientsg 2.37 1.30–4.29 
 Discussing post-discharge needs  with 
patients 
1.27 0.66–2.43 
Australia38 All stroke types Ability to walk on 
admission 
16665 (42 Hospitals) 1 process received vs 0 180-days  Case fatality 0.63  0.41-0.97 
 2 processes received  vs 0 0.46  0.31-0.68 
 3  processes received  vs 0 0.30  0.18-0.47 
 1 process received  vs 0 90-180-days  Quality of Life 
(QoL) 
12.53  −2.22-27.28 
 2 processes received  vs 0 16.67  0.30-33.05 
 3  processes received  vs 0 18.70  1.86-35.55 
New 
Zealand39 
All stroke types Age, initial FIM, 
pre-stroke FIM, and 
being European 
181 (3 hospitals) Swallowing assessment 1-year Poor outcome (death or 
moved from home) for  
swallowing recorded “no” 
3.2 0.97-10.7 
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Abbreviations: 
 ACE, angiotensin-converting enzyme; ADLs, Activities of Daily Living ; BI, Barthel Index; CNS, Canadian neurological scale; CT/MRI, 
computerized tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep vein thrombosis; FIM, functional independence 
measure; GCS, Glasgow coma scale; HR, hazard ratio; IS, ischemic stroke; LoS, length of hospital stay; mRS, modified Rankin Scale; NIHSS, 
national institute of health stroke scale; PT, physiotherapy; OR, odds ratio; OT, occupational therapy; RR, rate ratio; SAH, subarachnoid hemorrhage; 
SSS, Scandinavian stroke scale; SSV, six simple variable. 
a Organized stroke care included wards which encompassed multidisciplinary team-working, a physician with an interest in stroke, as well as 
taking into account the proportion of time spent (>50% of their length of stay) in such an environment. The wards that encompassed 
organized stroke care included neurology, elderly care, stroke specific unit and intensive care unit. 
b The complications that were considered in the analysis included pneumonia, urinary tract infection, pressure ulcer, falls, venous 
thromboembolism, and constipation. 
Table 1:  Studies eligible for the systematic literature review    Continued 
China40 Ischemic Stroke NIHSS 1951 ( 23 hospitals in 11 
major 
cities of China) 
Antiplatelet therapy 1-year case fatality 0.42 0.21–0.86 
 Recurrent cerebrovascular event 0.58 0.36–0.92 
 Functional improvement 1.25 1.02–1.52 
    
China41 First ever Ischemic 
Stroke 
NIHSS 7455 ( 132 hospitals) Stain use during hospitalization 3-month Case fatality 0.51 0.38–0.67 
   3-months dependency 0.95 0.81–1.11 
China42 Intracerebral 
Haemorrhage  
Stroke 
NIHSS 3218 (132 hospitals) Stain use during hospitalization 1-year Case fatality 0.49 0.27–0.86 
  1-year Good functional outcome  2.04 1.37–3.06 
Thailand43 Ischemic Stroke NIHSS 1222 (76 hosp)  Stroke unit admission Poor outcome (mRS  5-6 at 
discharge) (LoS=4 days) 
0.54  0.33-0.87 
Thrombolysis  0.09  0.03-0.23 
Aspirin within 48 hours 1.25  0.73-2.15 
Taiwan44 All stroke types NIHSS 30599 (39 hospitals) IV tPA for 2 hours 6-momth functional dependency 
(mRS≥2)  
0.52  0.35-0.76 
 Antithrombotics at discharge 6-momth risk of cardiovascular 
events and death   
0.41  0.35-0.47 
 Anticoagulation for atrial 
fibrillation at discharge 
0.59  0.44-0.80 
  Lipid-lowering agents at discharge 0.94  0.78-1.13 
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c Organized care index (OCI) is a summary score based on the presence of occupational therapy or physiotherapy, stroke team assessment, 
and admission to a stroke unit. A score of zero indicates that stroke patients received none of these services, and higher scores indicate access 
to more services. The “organized care” index was classified as having received 0, 1, 2, or 3 services. 
d n indicates number of applicable processes of care (PoC); i, number of PoC adhered to. 
e The 15 processes of care consisted of CT scan < 24 h since admission, swallow < 24 h since admission, allied health < 24 h since admission, 
incontinence addressed, discharged on antiplatelet agent, fever > 38.5 managed, documented premorbid function, documented discharge 
needs, regular neurology observations for the first 24 h of admission, physiotherapist within 24 h, occupational therapist within 24 h, speech 
pathologist within 24 h, enteric feeding if nil by mouth  > 48 h, aspiration avoidance, and DVT prophylaxis if not ambulant. 
f Secondary prevention included deep vein thrombosis prophylaxis, discharged on lipid-lowering medication, discharged on blood-pressure–
lowering medication, and discharged on antithrombotics. 
g Education to patients consisted of lifestyle advice, information on sexuality poststroke,  information about peer support, information on self-
management programs, carer training, and providing contact to patient.
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The majority (23/30) of the included studies used prospective recruitment while the rest 
(25, 26, 28-30, 35, 37) consisted of retrospective audits. Thirteen (16, 19, 20, 23, 24, 29, 
30, 32, 34, 35, 40, 41, and 43) included only patients with ischemic stroke, and two (33 and 
42) included only patients with intracerebral haemorrhage. The remainder included both 
ischemic and haemorrhagic stroke. Among those studies that included both types of stroke, 
six (15, 17, 18, 22, 28, and 36) excluded patients with subarachnoid haemorrhage.  
For the association between KPIs and patient outcomes, the majority (22) of the included 
studies used OR, six studies (16, 19, 23, 29, 38, 40) used HR while the remaining two 
(17,18) used rate RR. The included studies also used different measures for stroke severity 
as a case mix variable for adjustment to estimate the independent association between a 
KPI and a patient outcome. Twenty of the included studies used validated tools including 
National Institute of Health Stroke Scale (28,30,40-44), Scandinavian Stroke Scale (16-
21,29), Canadian Neurological Scale (32-34), Six Simple Variables (25,26), and Glasgow 
Coma Scale (36), while the remainder used stroke severity proxies such as level of 
consciousness, incontinence, dysphagia, dysphasia, paralysis, and disability.   
 
 
Reporting of published KPIs 
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As there were some variations in data definitions and analysis methods, several 
assumptions were made to allow easy comparison between the studies: 
Swallow/nutritional assessment – This single KPI comprised an assessment of swallowing, 
dysphagia, and/or nutritional risk. If separate data for both swallow and nutritional risk 
assessment (18, 21) were reported, we preferentially included data for swallow assessment. 
Antiplatelet drugs for ischemic stroke (IS) – Aspirin administration reported in two studies 
(25, 43) was combined with a KPI for antiplatelet drugs for ischemic stroke reported in 
seven studies (17, 18, 21, 23, 24, 28, 40).  
Early nurse/rehabilitation assessment – This combined indicator of early assessment by a 
nurse (24) and early assessment of rehabilitation needs (28).  
Early physiotherapy/mobilization – This combined five reports of early mobilization (18, 
21, 28, 30) with one (17) about early physiotherapy assessment. 
 
 
Selection of outcome measures 
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As there were minor variations in the approach to outcome analysis adjustments were made 
to the reported OR, HR, RR and confidence interval (CI) to allow comparisons between the 
studies. The online supplement Table S1 provides a summary of the adjustments made.  
Data reported in terms of poor outcome (33, 39, 43), disability (15, 22, 41, 44), death or 
disability (17, 30), or not returning home (27) post stroke were all combined as a “poor 
outcome” post stroke. Finally, the results on the association between KPIs and stroke case 
fatality were categorized at the end of scheduled follow up although the timing of follow up 
was included in sensitivity analyses. 
Key performance indicators 
There were 25 reported KPIs in total. The KPIs that were reported by at least a quarter of 
the eligible studies were swallow/nutritional assessment, stroke unit admission, and 
antiplatelets for ischemic stroke.  One study (18) reported eleven KPIs including hypoxia 
management, early medical assessment, antidepressant therapy, activities of daily living 
(ADLs) rehabilitation, home assessment, balance rehabilitation, secondary prevention on 
discharge, education to patients, discussing post-discharge needs with patients, intermittent 
catheterization, and constipation risk assessment.  
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Stroke unit admission was variably defined across the related studies (15,17,18, 21, 22, 24-
27,43). Two Danish studies (17,18) defined a “stroke unit” as a hospital department/unit 
that exclusively or primarily is dedicated to patients with stroke and which is characterized 
by multidisciplinary teams, a staff with a specific interest in stroke, involvement of 
relatives, and continuous education of the staff. In the Italian study (27), stroke unit was 
defined as a hospital ward with dedicated beds (at least 80% stroke admission) and with a 
dedicated stroke staff (at least one physician and one nurse) who work exclusively in the 
care of stroke patients.  
The online supplement Table S2 provides a list of reported KPIs and their frequencies out 
of the 30 studies. Table 2 indicates the reported KPIs and their association with patient 
outcomes.     
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Table 2: Reported KPIs and their association patient outcomes     
1. Reported KPIs and their association with case fatality 
KPI Study Treatment  
time 
End Follow up 
period 
OR/
HR/
RR 
95% CI 
CT/MRI brain imaging Europe15  3 months 0.70 0.40-1.30 
 Denmark17 1st day of LoS 3 months 1.35 1.24–1.46 
 UK (England)24 ≤24h 1 month 0.96  0.86-1.07 
 UK (Scotland)25 day 0 6 months 0.95  0.88–1.03 
 Spain28 <24h 1 year 0.71 0.36-1.41 
Neurological Assessment Chile35 On admission 1 month 2.02  0.77-5.30 
Thrombolysis Denmark19  1.4 year 0.66 0.49–0.88 
Stroke unit admission   Europe15  3 months 0.50 0.30-0.80 
 Denmark17 2nd day of LoS 3 months 0.76  0.69–0.83 
 Sweden22  2 years 0.81 0.72-0.92 
 UK (England)24  ≤4h  1 month 0.99  0.90-1.08 
 UK (Scotland)25 day 0 or 1 6 months 0.79  0.74–0.85 
 UK (Scotland)26  1 year 0.70 0.65-0.75 
 Italy27  2 years 0.79  0.68–0.91 
Swallow/nutritional assessment Denmark17 2nd day of LoS 3 months 0.69  0.61–0.76 
 UK (England)24  ≤72h 1 month 0.76 0.67- 0.87 
 UK (Scotland)25 day 0  6 months 0.95  0.86–1.04 
 Spain28  1 year 0.81  0.58-1.14 
 Chile35 ≤48h 1 month 0.52 0.26-1.04 
Antiplatelets for ischemic stroke Denmark17 2nd day of LoS 3 months 0.71  0.62–0.81 
 Sweden23 - 3 months 0.83 0.68-1.01 
 UK (England)24  ≤72h 1 month 0.46  0.42-0.50 
 UK (Scotland)25 day 0 or 1 6 months 0.54  0.49–0.58 
 Spain28 < 48 hours 1 year 0.77 0.50-1.19 
 China40 LoS 1 year 0.42 0.21–0.86 
Anticoagulants for ischemic stroke Denmark16 Acute LoS 4 years 0.52 0.40-0.69 
 Denmark17 By 14th day 3 months 0.41  0.31–0.52 
 Sweden23 - 3 months 0.58 0.44–0.76 
 Spain28  1 year 0.59 0.33-1.05 
Blood pressure lowering therapy Sweden23 - 3 months 1.00 0.87–1.14 
 Spain28  1 year 0.53 0.35-0.82 
Hyperthermia management Spain28  1 year 1.50 0.56-4.00 
Lipid management Sweden23 - 3 months 0.78 0.67–0.91 
 Spain28  1 year 0.78 0.52-1.16 
 Greece29 At discharge 10 years 0.43 0.29-0.61 
 Canada33 Acute LoS 6 months 0.2  0.1–0.3 
 China41 LoS 3months 0.51 0.38–0.67 
 China42 Acute LoS 1 year 0.49 0.27–0.86 
DVT Prophylaxis Spain28  1 year 1.02 0.63-1.67 
 Canada32 Acute LoS 1 year 0.33  0.22–0.50 
Early medical assessment UK (England)24  ≤24h 1 month 0.88 0.80- 0.97 
Early nurse/rehabilitation assessment UK (England)24 ≤24h 1 month 0.90  0.82-0.99 
 Spain28  1 year 0.68 0.48-0.94 
Early physiotherapy/mobilization Denmark17 2nd day of LoS 3 months 0.81  0.73–0.88 
 Spain28  1 year 0.65 0.45-0.95 
Occupational therapy assessment Denmark17 2nd day of LoS 3 months 0.83 0.75–0.91 
Antidepressant therapy Denmark20 LoS 1 month 0.28 0.18–0.43 
      
 
 
 
 
23 
 
  
 
    
Table 2: Reported KPIs and their association patient outcomes    Continued 
2.  Reported KPIs and their association with poor outcome 
KPI Study Treatment  
time 
End of Follow up 
period 
OR/
HR/
RR  
95% CI 
CT/MRI brain imaging Europe15  3 months 1.45 0.39–7.4 
Thrombolysis Thailand43  LoS=4 days 0.09  0.03-0.23 
 Taiwan44 3h of onset 6 months 0.52 0.35-0.76 
Neurological Assessment USA30  LoS 1.13  0.59-2.17 
Stroke unit admission   Thailand43  LoS=4 days 0.54  0.33-0.87 
 Europe15  3 months 1.3 0.6–1.76 
 Italy27  2 years 0.85  0.74–0.97 
 UK (Scotland)26  6 months 0.84 0.78-0.90 
 Sweden22  2 years 0.79 0.66-0.94 
Swallow/nutritional assessment Thailand43  LoS=4 days 0.54  0.33-0.87 
 New Zealand39  1 year 0.31 0.09-1.03 
 USA30  LoS 0.64  0.43-0.94 
Antiplatelets for ischemic stroke China40 LoS 1 year 0.80 0.66-0.98 
 Thailand43 48h LoS=4 days 1.25 0.73-2.15 
Blood pressure lowering therapy USA30  LoS 1.00  0.67-1.50 
Hyperthermia management USA30 All episodes LoS 0.71 0.35-1.41 
Hypoxia management USA30 All episodes LoS 0.26  0.09-0.73 
DVT Prophylaxis USA30  LoS 0.60  0.37-0.96 
 Australia37  26 days 1.72 1.23-2.44 
Early physiotherapy/mobilization USA30  LoS 0.69  0.42-1.14 
ADLs  rehabilitation Australia37  26 days 0.99 0.32-3.03 
Home assessment Australia37  26 days 0.16 0.10-0.27 
Balance rehabilitation Australia37  26 days 1.85 1.20-2.86 
Secondary prevention on discharge Australia37  26 days 0.50 0.28-0.89 
Education to patients Australia37  26 days 0.42 0.23-0.77 
Discussing post-discharge needs  with 
patients 
Australia37  26 days 0.79 0.41-1.52 
Lipid management  China41 Acute LoS 3 months 0.95 0.81–1.11 
 China42 Acute LoS 1 year 0.49 0.33-0.73 
 Canada33 Acute LoS At discharge 0.6  0.4–0.9 
2.  Reported KPIs and their association with prolonged length of hospital stay 
Stroke unit admission   Denmark18 2nd day  0.71  0.65–0.77 
Antiplatelets for ischemic stroke Denmark18 2nd day  0.80  0.73–0.87 
Anticoagulants for ischemic stroke Denmark18 14th day  0.78  0.62–0.98 
CT/MRI brain imaging Denmark18 2nd day  0.82 0.74–0.91 
Swallow/nutritional assessment Denmark18 2nd day  0.78 0.69–0.87 
Constipation risk assessment Denmark18 2nd day  0.70 0.63-0.78 
Early physiotherapy/mobilization  Denmark18 2nd day  0.67 0.61–0.73 
Occupational therapy assessment  Denmark18 2nd day  0.85  0.80–0.91 
Intermittent catheterization Denmark18 2nd day  0.77 0.64–0.92 
DVT Prophylaxis Denmark18 2nd day  0.82 0.71–0.95 
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Table 2: Reported KPIs and their association patient outcomes    Continued 
4.  Reported KPIs and their association with medical complications 
KPI Study Treatment  
time 
End of Follow up 
period 
OR/
HR/
RR 
(95% CI) 
CT/MRI brain imaging Denmark21  LoS=13days 1.52 1.35–1.72 
Neurological Assessment Chile35 On admission 30 days 1.07  0.79-1.44 
Stroke unit admission   Denmark21  LoS=13days 0.79 0.68–0.92 
Swallow/nutritional assessment Chile35 ≤48h 30 days 1.58  0.60- 4.15 
 Denmark21  LoS=13days 0.97 0.84–1.11 
 USA31  LoS=5days 0.47 0.38-0.57 
Antiplatelets for ischemic stroke Denmark21  LoS=13days 0.95 0.79–1.15 
Anticoagulants for ischemic stroke Denmark21  LoS=13days 0.59  0.45–0.76 
Early physiotherapy/mobilization Denmark21  LoS=13days 0.43  0.35–0.53 
Occupational therapy assessment Denmark21  LoS=13days 1.10  0.94–1.27 
Thrombolysis Denmark19  1.4 year 0.59 0.24–1.47 
5.  Reported KPIs and their association with stroke recurrence 
Antiplatelets for ischemic stroke China40 LoS 12 months 0.58 0.36–0.92 
Anticoagulants for ischemic stroke Taiwan44 At discharge 6 months 0.59 0.44-0.80 
Lipid management Taiwan44 At discharge 6 months 0.94 0.78-1.13 
 Greece29 At discharge 10 years 0.65 0.39- 0.97 
DVT Prophylaxis Taiwan44 At discharge 6 months 0.41 0.35-0.47 
Thrombolysis Denmark19  1.4 year 1.05 0.68–1.64 
 
Abbreviations: ADLs, activities of daily living ; CT/MRI, computerized tomography/magnetic resonance 
imaging; CI, confidence interval; DVT, deep vein thrombosis; HR, hazard ratio; KPI, key performance 
indicator; LoS, length of hospital stay; OR, odds ratio; RR, rate ratio. 
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Association between individual KPIs and lower risk for case fatality at the end of 
scheduled follow up 
The median time of scheduled follow up for the studies reporting on the association 
between individual KPIs and case fatality was one year; range from one month to 10 years. 
Significant reductions in case fatality were observed across multiple studies for stroke unit 
admission (15, 17, 22, 25-27), swallow/nutritional assessment (17,24), antiplatelets for 
ischemic stroke (17, 40, 24, 25), anticoagulants for ischemic stroke (16, 17, 23), lipid 
management (23, 29, 33, 41, 42), early nurse/rehabilitation assessment (24,28), early 
physiotherapy/mobilization (17, 28). In addition, significant associations within single 
studies were observed for DVT prophylaxis (32) and blood pressure lowering therapy (28).   
In contrast, several studies reported wide confidence intervals and no statistically 
significant association between the reported KPIs and stroke case fatality; stroke unit 
admission (24), swallow/nutritional assessment (25, 28, 35), antiplatelets for ischemic 
stroke (23, 28), anticoagulants for ischemic stroke, lipid management (28), DVT 
prophylaxis (28) and blood pressure lowering therapy (23). Surprisingly, in one study (17) 
the CT/MRI brain imaging was associated with increased risk of early case fatality (RR: 
1.35, 95% CI: 1.24-1.46), while in other studies (15, 24, 25, 28) no evidence for an 
association of CT/MRI brain imaging and stroke case fatality was found. 
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Figure 2 summarises the primary meta-analysis results regarding the associations between 
individual KPIs and stroke case fatality at the end of follow up. The KPIs that were 
associated with lower risk for case fatality include stroke unit admission (OR: 0.79, 95% 
CI: 0.72-0.87; I2=88%), swallow/nutritional assessment (OR: 0.78, 95% CI: 0.66-0.92; 
I2=79%), antiplatelets for ischemic stroke (OR: 0.61, 95% CI: 0.50-0.74; I2=90%), 
anticoagulants for ischemic stroke (OR: 0.51, 95% CI: 0.43-0.61; I2=12%), lipid 
management (OR: 0.52, 95% CI: 0.38-0.71; I2=80%), and early physiotherapy/mobilization 
(OR: 0.78, 95% CI: 0.67-0.91; I2=21%). However, the significant associations of stroke 
unit admission, swallow/nutritional assessment, antiplatelets for ischemic stroke and lipid 
management were complicated by substantial heterogeneity (I2>50%). When analyzed at a 
fixed time point, swallow/nutritional assessment (OR: 0.72, 95% CI: 0.66-0.79; I2), 
antiplatelets for ischemic stroke (OR: 0.64, 95% CI: 0.44-0.93; I2) and lipid management 
(OR: 0.64, 95% CI: 0.42-0.97; I2) were associated with a lower risk for early case fatality 
(up to three months post stroke), but the heterogeneity was reduced for swallow/nutritional 
assessment (I2=1%) only. Stroke unit admission (OR: 0.77, 95% CI: 0.71-0.82; I2), 
antiplatelets for ischemic stroke (OR: 0.57, 95% CI: 0.45-0.72; I2) and lipid management 
(OR: 0.45, 95% CI: 0.27-0.74; I2) were associated with lower risk for late case fatality 
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(beyond three months post stroke), but the heterogeneity was reduced for antiplatelets for 
ischemic stroke (I2=34%) only.  
 The meta-analysis showed no evidence for the association between the stroke case fatality 
and DVT prophylaxis, blood pressure lowering therapy, early nurse/rehabilitation 
assessment, and CT/MRI brain imaging.   
[Insert Figure 2 here] 
The sensitivity analysis excluding those that used HR or RR produced results that were 
similar to those  in Figure 2 (data not shown): stroke unit admission (OR: 0.79, 95% CI: 
0.71-0.89), swallow/nutritional assessment (OR: 0.82, 95% CI: 0.69-0.98), antiplatelets for 
ischemic stroke (OR: 0.53, 95% CI: 0.44-0.63), and lipid management (OR: 0.47, 95% CI: 
0.30-0.74) remained associated with lower risk for case fatality, and  there was no evidence 
for the association between the stroke case fatality and DVT prophylaxis, early 
nurse/rehabilitation assessment, and CT/MRI brain imaging.   
 
Significant associations within single studies were observed for thrombolysis (19), early 
medical assessment (24), OT assessment (17), and antidepressant therapy (20), but there 
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was no evidence for the association between stroke case fatality and hyperthermia 
management (28), and neurological assessment (35). 
Association between individual KPIs and the risk for poor outcome 
For studies reporting on the association between individual KPIs and poor outcome the 
available follow up periods were between four days and two years, with a mean of 282 
days. 
KPIs that were reported to be associated with the lower risk for poor outcome included 
thrombolysis (43, 44), stroke unit admission (22, 26, 27, 43), swallowing/nutritional 
assessment (30, 43), antiplatelets for ischemic stroke (40), DVT prophylaxis (30), and lipid 
management management (33, 42). However, some studies found no evidence of an 
association with poor outcome and stroke unit admission (15); swallowing/nutritional 
assessment (39), antiplatelets for ischemic stroke (43), DVT prophylaxis (37) and lipid 
management (41).  
As summarized in Figure 3, the meta-analysis showed that the KPIs associated with the 
lower risk for poor outcome were stroke unit admission (OR: 0.83, 95% CI: 0.77-0.89; 
I2=15%) and swallowing/nutritional assessment (OR: 0.58, 95% CI: 0.43-0.78, I2=0%) 
29 
 
while there was no evidence for the association with poor outcome for thrombolysis, 
antiplatelets for ischaemic stroke, DVT prophylaxis, and lipid management.   
[Insert Figure 3 here] 
Several individual studies reported significant associations between lower risk for poor 
outcome and hypoxia management (30); home assessment, secondary prevention on 
discharge, and education to patients (37).  No association with poor outcome was found for 
CT/MRI brain imaging (15); neurological assessment, blood pressure lowering therapy, 
hyperthermia management and early physiotherapy/mobilization (30); ADLs rehabilitation, 
balance rehabilitation and discussing post-discharge needs with patients (37).  
All the studies included for the primary meta-analysis about the association of KPIs with 
poor outcome used ORs, except one Chinese study (40). After excluding that study, 
antiplatelets for ischemic stroke remained with a single study (43) which showed no 
association with poor outcome (OR: 1.25, 95% CI: 0.73-2.14). 
Association between individual KPIs and relative length of hospital stay 
A single Danish study (18), reported that a shorter relative length of hospital stay  was 
associated with stroke unit admission, antiplatelets and anticoagulants for ischemic stroke, 
CT/MRI brain imaging, early physiotherapy/mobilization, occupational therapy assessment, 
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swallowing/nutritional assessment, and DVT prophylaxis, with rate ratio ranging from 0.67 
(0.61–0.73) for early physiotherapy/mobilization to 0.85 (0.80–0.91) for occupational 
therapy assessment. 
Association between individual KPIs and the risk for medical complications and 
stroke recurrence  
Stroke unit admission, anticoagulants for ischemic stroke, and early 
physiotherapy/mobilization (21), as well as swallow/nutritional assessment (31) were found 
to be associated with lower risk for medical complications (OR: 0.79; 0.68–0.92; I2; 0.59, 
0.45–0.76; I2 and 0.43, 0.35–0.53; I2; 0.47, 0.38-0.57; I2 respectively). By contrast, 
CT/MRI brain imaging was associated with a greater risk for medical complications with 
(1.52, 1.35–1.72; I2) (21). Other studies with wide confidence intervals did not show 
evidence for the association between the occurrence of medical complications and 
neurological assessment (35); swallow/nutritional assessment (21, 35); antiplatelets for 
ischemic stroke, occupational therapy assessment (21); and thrombolysis (19).   
KPIs that were reported to be associated with lower recurrence rate for stroke included 
antiplatelets for ischemic stroke (40), anticoagulants for ischemic stroke and DVT 
prophylaxis (44), and lipid management (29). However, in one study (21) evidence for the 
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association between lipid management and stroke recurrence was not found (44), and there 
was no evidence of an association with thrombolysis (19). 
Association between adherence to groups of KPIs and the risk for case fatality 
Seven studies (17, 24, 25, 32, 34, 36, 38) had consistent findings whereby adherence to a 
combination of several KPIs (“bundle”) was associated with a greater decrease in stroke 
mortality. A lower risk for poor outcome was also reported when full stroke care bundle 
was achieved (25, 36). An Australian study (38) also showed that achieving full care bundle 
was associated with better quality of life at three to six months post stroke. Increased 
adherence to stroke care KPIs (18) was associated with shorter length of hospital stay (data 
are not shown in Table 3).  
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Table 3: Association between the number of KPIs achieved and patient outcomes 
 Case Fatality Poor Outcome Quality of Life 
Study FU Period Number  of 
processes 
HR 95%CI FU Period Number of 
processes 
OR/
HR/
RR 
95%CI FU Period Number of 
processes 
OR/
HR/
RR 
95%CI 
Denmark17 3 months 1 vs 0 0.94  0.65-1.49 
 
        
  2 vs 0 0.78  0.54–1.02 
 
        
  3 vs 0 0.60  0.42–0.78 
 
        
  4 vs 0 0.61 0.42–0.79 
 
        
  5 vs 0 0.45 0.31–0.60 
 
        
  6 vs 0 0.48 0.31–0.65         
            
UK (England)24 1 month 5-6 vs 0-4 0.74 
 
0.66- 0.83         
             
UK (Scotland)25 6 months 0 vs 4 2.26 
 
1.60–3.21 6 months 0 vs 4 1.43 1.02-2.00     
  1 vs 4 1.67 1.45–1.93  1 vs 4 1.35 1.19-1.54     
  2 vs 4 1.44 
 
1.31–1.59  2 vs 4 1.19 1.10-1.32     
  3 vs 4 1.17 1.08-1.27  3 vs 4 1.10 1.02-1.18     
            
Canada32 12 months OCI 1 vs 0 0.69  0.44–1.09         
  OCI 2 vs 0 0.39  0.25–0.62         
  OCI 3 vs 0 0.40 0.25–0.64         
             
Australia36 6 months All or n-1 0.48 0.21-1.09 6 months All or n-1 0.59 0.30-1.16     
  All 0.31 0.06-1.52  All 0.32 0.10-1.04     
             
Australia38 6 months 1 vs 0 0.63  0.41-0.97     3-6 months 1 vs 0 12.5
3  
−2.22-27.28 
  2 vs 0 0.46  0.31-0.68      2 vs 0 16.6
7  
0.30-33.05 
  3 vs 0 0.30  0.18-0.47      3 vs 0 18.7
0  
1.86-35.55 
             
Canada34 1 month 2-3 vs 0-1 0.23 0.19-0.28         
             
Abbreviations: CI, confidence interval; FU, Follow up; HR, hazard ratio; n, number of applicable processes of care; OCI, Organized care index; 
                          OR, odds ratio; RR, rate ratio.
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Overall (see Online Supplement Table 3), only stroke unit admission, swallow/nutritional 
assessment, antiplatelets for ischemic stroke, anticoagulants for ischemic stroke, lipid 
management and early physiotherapy/mobilization were found to be significantly 
associated with improved outcomes after a meta-analysis of two or more studies. 
Thrombolysis results were associated with reduced poor outcome in two studies, but the 
combined analysis was not significant due to substantial heterogeneity. Data were very 
limited for the outcomes of length of stay, stroke recurrence or medical complications. 
 
DISCUSSION 
The publications we have reviewed provide a large and diverse body of evidence on 
whether quality of care, as measured by adherence with a KPI, is associated with improved 
clinical outcomes in patients hospitalized with stroke. Our primary meta-analysis indicated 
that several  KPIs including stroke unit admission, swallowing/nutritional risk assessment, 
antiplatelets for ischemic stroke, anticoagulants for ischemic stroke, lipid management and 
early physiotherapy/mobilization were associated with a reduction in case fatality or poor 
outcome.  
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The strong association of stroke unit care with improved outcomes could be anticipated 
from a substantial number of RCTs (45). Our review confirms this across a range of studies 
in routine care. Given the evidence for specialized multidisciplinary stroke unit care in 
stroke (45), one might also expect to see benefits associated with early nurse or 
rehabilitation assessment and early medical assessment (24), as well as occupational 
therapy assessment (17). These indicators lack direct evidence from randomised trials but 
may possibly be markers for admission to a stroke unit and multidisciplinary stroke care. 
However, there were no comparable data from many studies about early medical 
assessment, early nurse or rehabilitation assessment or early occupational therapy 
assessment for our review.  
 
Our finding of a reduced risk of case fatality after early physiotherapy/mobilization was in 
accordance with the literature about stroke unit care (45), and some small RCTs (46) but 
not consistent with recent RCTs of very early mobilisation (47). However, the recent 
AVERT trial tested mobilisation at an earlier stage than in routine care so the optimal 
timing of mobilization remains  unclear, and very early intensive mobilization within 24 
hours may carry some hazard (47). 
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Our meta-analysis showed that swallow or nutritional assessment was associated with 
lower risk for both mortality and disability post stroke. This finding was consistent with a 
randomised controlled trial (9) which found that reinforcement of multidisciplinary 
management of swallowing dysfunction was significantly associated with lower risk for 
death or dependency. Thus, swallowing or nutritional assessment may be of paramount 
importance.  The current meta-analysis also showed that early antiplatelet use for ischemic 
stroke was associated with reduction in case fatality, and this was consistent with the results 
from a previous systematic review (48) of eight randomized trials. It showed that early 
antiplatelet therapy was associated with mortality reduction at a final follow-up between 
one and six months. However, our review showed greater apparent benefit than the 8% 
reduction in case fatality that was reported in the review of randomised trials (48). 
However, a recent individual patient data meta-analysis of aspirin trials (49) confirms an 
important short term benefit of aspirin therapy in preventing recurrent cerebral ischemia 
and that benefits may be greater than previously estimated.  Our meta-analysis finding of a 
reduced risk of stroke case fatality associated with lipid management was consistent with 
the results from a meta-analysis (50) of 42 randomised trials.  
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One major disagreement with the RCTs is that our meta-analysis also showed that early 
anticoagulant use for ischemic stroke were associated with a reduction in early and late case 
fatality. However, this finding was not supported by a review (51) of 24 randomized 
clinical trials. As the studies included in our review were neither randomized nor blinded, 
the apparent effects of antiplatelets and anticoagulants for ischemic stroke may have been 
overestimated due to selection bias and incomplete adjustment for confounders. 
Alternatively KPIs may also reflect other important and unmeasured aspects of care which 
would not be tested in a well-designed RCT.  Additionally, the duration of follow-up for 
the studies included in our meta-analysis varied between three and 48 months (mean: 16.5 
±21.4 months) while the duration of follow-up in the trials was generally shorter.  This 
short-term follow-up may lead to missing a significant proportion of deaths that occur after 
one month, and disability is best assessed between three to six months when most of the 
recovery has taken place (51).  
 
Our review has also identified some areas with inconsistent evidence of the association of 
KPIs with outcome. Deep vein thrombosis (DVT) prophylaxis was found to be associated 
with significant benefits in studies in Canada (32) and the USA (30) but not in Spain (28).  
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However, a meta-analysis of RCTs has failed to show improvements in survival or 
independence (51).  
 
Regarding thrombolysis, in two studies included for our review (43, 44) thrombolysis was 
associated with a lower risk for poor functional outcome, and this was consistent with the 
systematic review of the RCTs (52). However, because of high heterogeneity (I2=88%) 
between the two studies reviewed, the summary effect was not statistically significant.                                        
 
Our review showed that CT/MRI brain imaging and neurological assessment were not 
associated with any reported patient outcomes. This may be due to several reasons. First, 
the assessment itself, if not combined with adequate care, is unlikely to show any difference 
in outcome. For instance, once ischemic stroke is diagnosed with brain imaging, further 
management by intravenous tissue plasminogen activator was found to be effective.  It was 
however recently reported that only 3% of low-income, 19% of lower-middle-income, 33% 
of upper-middle-income, and 50% of high-income-countries use it (53). Second, the 
increased risk of early case fatality (17) and medical complications (21) that were reported 
after early CT/MRI brain imaging in two Danish studies, was most likely due to reverse 
causality; patients who deteriorated during the first hours after hospitalization were more 
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likely to receive an early CT/MRI brain imaging, and also had a greater risk of death or 
medical complications (21). Third, some of the analyses of data may have been hampered 
by small sample sizes, and lack of statistical power to show the differential benefit.    
 
Adherence to an individual measure in isolation may not have a clinically detectable impact 
on outcomes, making determination of an effect more difficult (54). However adherence to 
several KPIs was always associated with improved outcomes.  
 
Strengths and weaknesses 
Our systematic review has several strengths including searching a wide range of databases 
using standardised methodology. Furthermore, the review report was based on the PRISMA 
guidelines. The studies that were included in our review involved large sample sizes in 
general, allowing sufficient statistical power and enhancing the external validity of the 
results. One study (15) was multinational, and 12 studies (16, 17, 19, 22, 23, 27, 37, 38, 41-
44) involved nationwide datasets. The remaining studies were conducted regionally with 
the recruitment of participants from between three (39) to 222 hospitals (31). Additionally 
we only conducted analyses using data from studies that corrected for patient casemix (age 
and stroke severity). Our approach to meta-analysis has used a conservative random-effects 
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approach to acknowledge the diversity of studies identified. Finally, we performed a 
sensitivity analysis to evaluate the robustness of our findings. 
 
We must acknowledge some weaknesses. We did not use any scoring system to assess risk 
of bias in included studies, but simply included large register studies reporting independent 
association of KPIs with patient outcomes after adjusting at least two variables including 
age and stroke severity. Second, the review was based on data from observational studies 
with different follow-up time periods and designs.  Third, although we have only included 
data that used a multivariable analysis to correct for patient casemix, there remains the 
possibility that the patient outcomes were influenced by unmeasured or residual 
confounding factors such as indication bias or factors related to the nonrandomized study 
design rather than the reported KPIs themselves. Fourthly, our review could be subject to 
publication bias because our search strategy was limited to electronic databases and 
references known to the authors, and manuscripts published in English only. Fifth, there is 
a potential concern about combining results from studies from different settings and using 
different research methodologies. For instance, there were different measures for stroke 
severity for case mix adjustment, different models of stroke unit, and different models of 
implementing or measuring the KPIs. Finally, we were limited to a few studies reporting 
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data on important outcomes such as the length of hospital stay and quality of life, and none 
of the studies considered the cost of care which is clearly important in a disabling condition 
such as stroke.   
 
CONCLUSION 
Our review found that the most frequently reported KPIs for stroke care were 
swallow/nutritional assessment, stroke unit admission, antiplatelets for ischemic stroke, 
CT/MRI brain imaging, anticoagulants for ischemic stroke, lipid management, deep vein 
thrombosis (DVT) prophylaxis, and early physiotherapy/mobilization. Stroke unit 
admission and early interventions including swallowing/nutritional risk assessment, 
antiplatelets for ischemic stroke, anticoagulants for ischemic stroke, lipid management and 
early physiotherapy/mobilization were all associated with better patient outcomes. 
Achieving a combination of several KPIs was always associated with a better outcome.  
Both policy makers and health care professionals should be encouraged to implement the 
KPIs for stroke management that are reliable and meaningful for regularly monitoring the 
quality of stroke care. Future research could focus on novel stroke care quality indicators, 
particularly in the post-acute period. 
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Figure 2: Association between individual KPIs and lower risk for case fatality  
Abbreviations: CT/MRI, computerized tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep 
vein thrombosis; I2, heterogeneity; IV, inverse variance; KPI, key performance indicator; N, number of. 
 
Figure 3: Association between individual KPIs and lower risk for poor outcome 
 
Abbreviations: CT/MRI, computerized tomography/magnetic resonance imaging; CI, confidence interval; DVT, deep 
vein thrombosis; I2, heterogeneity; IV, inverse variance; KPI, key performance indicator; N, number of. 
